Stay updated on Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.

Latest updates to the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedNew entry added: revision v3.5.3. The corresponding deletion shows v3.5.2 is superseded, reflecting a page version update.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.0 to v3.5.2, with no other study-record changes shown.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.4.3 was added to the Record History and Revision: v3.4.2 was removed, updating the list of version changes for the study record.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry v3.4.2 was added to the Study Record Versions and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.1 is now listed. The previous government funding operating-status notice associated with v3.4.0 has been removed.SummaryDifference0.8%

Stay in the know with updates to Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.